Bekaert: Notice of Extraordinary General Meeting of Shareholders

Notice of Extraordinary General Meeting of Shareholders

The shareholders and the holders of debentures are requested to attend the Extraordinary General Meeting of Shareholders to be held on Tuesday 25 February 2025 at 16:30 p.m. at the offices of the Company, Bekaertstraat 2, 8550 Zwevegem (Belgium).

Attachment

p250124E – EGM1 Notice

Bekaert: Notice of Extraordinary General Meeting of Shareholders

Net Asset Value(s)

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity

Share Buy-back programme at SP Group A/S

GPTBots Collaborates with Member of the Stargate Project on LLMs

CIB Marine Bancshares, Inc. Announces 2024 Results

Topics

Net Asset Value(s)

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity

Share Buy-back programme at SP Group A/S

GPTBots Collaborates with Member of the Stargate Project on LLMs

CIB Marine Bancshares, Inc. Announces 2024 Results

RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS

Form 8.5 (EPT/RI) – Alliance Pharma plc

Municipality Finance issues RON 106,5 million notes under its MTN programme

Related Articles

Net Asset Value(s)

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity

Share Buy-back programme at SP Group A/S

GPTBots Collaborates with Member of the Stargate Project on LLMs

CIB Marine Bancshares, Inc. Announces 2024 Results

Company

Headlines

Net Asset Value(s)

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity

Share Buy-back programme at SP Group A/S

GPTBots Collaborates with Member of the Stargate Project on LLMs

Newsletter